An overview of proteomics approaches applied to biopharmaceuticals and cyclotides research

J Proteomics. 2013 Nov 20:93:224-33. doi: 10.1016/j.jprot.2013.06.009. Epub 2013 Jun 15.

Abstract

The evolution in proteomics approaches is notable, including quantitative proteomics and strategies for elucidation of post-translational modifications. Faster and more accurate mass spectrometers as well as cleverer bioinformatics tolls are making the difference in such advancement. Among the wide range of research in plant proteomics, biopharmaceutical production using plants as "biofactories" and the screening of new activities of new molecules, in this case, peptides, are quite important regarding translational proteomics. The present review is focused on "recombinant proteins and bioactive peptides", with biopharmaceuticals and cyclotides chosen as examples. Their application and challenges are focused on a "translational proteomics" point of view, in order to exemplify some new areas of research based on proteomics strategies. This article is part of a Special Issue entitled: Translational Plant Proteomics.

Keywords: Biopharmaceuticals; Cyclotide; High resolution mass spectrometry; Molecular farming; Plant translational proteomics; Post-translational modification.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antibodies, Monoclonal / biosynthesis
  • Antigens / biosynthesis
  • Cyclotides / biosynthesis*
  • Humans
  • Insulin / biosynthesis
  • Mass Spectrometry
  • Plants / metabolism*
  • Protein Processing, Post-Translational
  • Proteomics / methods*
  • Recombinant Proteins / biosynthesis*

Substances

  • Antibodies, Monoclonal
  • Antigens
  • Cyclotides
  • Insulin
  • Recombinant Proteins